Evidence. Care. Accountability.Contact the desk
Our standards

Research explained

BPC-157 in a high-dose lithium rat experiment

The experiment does not justify changing lithium treatment or adding BPC-157 to psychiatric care.

On this page

Evidence dossier

The report behind the claim

The authors reported attenuation of the toxic syndrome and several associated injury measures. The experiment does not justify changing lithium treatment or adding BPC-157 to psychiatric care.

Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157.

Design
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Participants or model
Rats exposed to a severe lithium regimen
Endpoint
Weakness, pressure, circulation and multiorgan lesions
Finding on record
The authors reported attenuation of the toxic syndrome and several associated injury measures.
Limits of inference
The experiment does not justify changing lithium treatment or adding BPC-157 to psychiatric care.
Read the publication

The experiment in view

The study used rats exposed to a severe lithium regimen. Its principal measures were weakness, pressure, circulation and multiorgan lesions. The authors reported attenuation of the toxic syndrome and several associated injury measures.

Reading the result closely

Overdose-like experimental exposure differs from a monitored maintenance prescription. The study cannot identify a safe combined regimen or replace blood-level monitoring. Its proposed vascular mechanism is a research hypothesis to investigate rather than a consumer strategy for avoiding a medication's adverse effects.

The boundary of the finding

The experiment does not justify changing lithium treatment or adding BPC-157 to psychiatric care.

Related evidence, kept separate

BPC-157 in an experimental magnesium-overdose model examines weakness, electrolyte changes, tissue lesions and membrane potential. Here, the measured endpoint was weakness, pressure, circulation and multiorgan lesions. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.

On the record

The documents supporting this report.

  1. BPC-157 in a high-dose lithium rat experiment — original indexed research

The continuing record

More from the report

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review